During the course 60 cases of benign and malignant gastrointestinal tumors as well as inflammatory conditions of the esophagus, stomach, small bowel, and colorectum will be presented.
The course is limited to lesions of the tubular gastrointestinal tract. Lymphomas and lesions of the pancreatico-biliary tract and liver will not be addressed. Both common and rare conditions will be presented and set into a clinical context. On each day, 20 cases will be extensively discussed by an interactive approach. Particular attention will be paid to diagnostic criteria and differential diagnoses. The value and limitations of immunohistochemistry will be critically discussed. A comprehensive review and update on histopathology will be provided.
The new WHO classification of GI tumors: pros and cons will be discussed. The participants will have the opportunity to review 60 digitized cases (virtual microscopy) four weeks prior to and after the course.
Professor of Pathology, Chairman, Department of Pathology, Klinikum Bayreuth, Germany
Professor of Pathology, Department of Pathology, University of Miami Hospital & Clinics (USA)
This course is designed for practicing pathologists as well as senior pathology trainees. Due to the current pandemic of coronavirus (COVID-19), distance regulation, and hygiene measures, the course could be limited to 50 participants.
Vaccination against coronavirus (COVID-19) is required for attendance of the course.
An application has been made to the EACCME for CME accreditation of this event.
Wednesday: Start with the registration 7.00 - 8.00 a.m.
Friday: End of the course 4.30 p.m.
We are happy to keep you posted.